Earnings Feed
Start Free
Home/Filings/4/0001209191-21-045645
4//SEC Filing

GHALIE RICHARD G 4

Accession 0001209191-21-045645

CIK 0001262104other
View on SEC.govCompany Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 6:52 PM ET

Size

15.1 KB

Accession

0001209191-21-045645

Insider Transaction Report

Form 4
Period: 2021-07-01
MEI Pharma, Inc.MEIP
GHALIE RICHARD G
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-07-01+320,000→ 320,000 total
    Exercise: $2.95Exp: 2031-07-01→ Common Stock (320,000 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $3.49Exp: 2030-07-02→ Common Stock (150,000 underlying)
    150,000

  • Stock Option (Right to Buy)

    Exercise: $3.55Exp: 2031-05-03→ Common Stock (75,000 underlying)
    75,000

  • Stock Option (Right to Buy)

    Exercise: $2.88Exp: 2027-07-07→ Common Stock (65,000 underlying)
    65,000

  • Stock Option (Right to Buy)

    Exercise: $2.52Exp: 2029-07-01→ Common Stock (150,000 underlying)
    150,000

  • Stock Option (Right to Buy)

    Exercise: $1.21Exp: 2026-03-07→ Common Stock (130,000 underlying)
    130,000

  • Stock Option (Right to Buy)

    Exercise: $1.38Exp: 2026-07-14→ Common Stock (25,000 underlying)
    25,000

  • Stock Option (Right to Buy)

    Exercise: $4.28Exp: 2028-07-12→ Common Stock (130,000 underlying)
    130,000
Footnotes (7)
  • [F1]One-quarter of such options shall vest on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
  • [F2]All options are currently exercisable.
  • [F3]One-quarter of such options vested on July 7, 2018, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 7, 2018.
  • [F4]One-quarter of such options vested on July 12, 2019, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
  • [F5]One-quarter of such options vested on July 1, 2020, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
  • [F6]One-quarter of such options vested on July 2, 2021, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.
  • [F7]One-quarter of such options shall vest on May 3, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on May 3, 2022.

Documents

1 file

Issuer

MEI Pharma, Inc.

CIK 0001262104

→
Entity typeother

Related Parties

1
  • filerCIK 0001156208

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:52 PM ET
Size
15.1 KB
View on SEC.gov